Broad GI
- DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
- Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies
- Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
- Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
- Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms
- HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
BTC
- Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
- Cancer Treatment Reviews
- Critical Reviews in Oncology/Hematology
- Molecular profiling of biliary tract cancer: a target rich disease
- Targets for therapy in biliary tract cancers: the new horizon of personalized medicine
- Genetic analysis in the clinical management of biliary tract cancer
- Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
- New developments in systemic therapy for advanced biliary tract cancer
Gastric
- Cancer Treatment Reviews
- Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma
- Gastric Cancer: Establishing Predictors of Biologic Behavior with Use of Population-Based Data
- Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
- Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer
- Update on Epstein-Barr virus and gastric cancer (Review)
- Epstein–Barr Virus Infection and Gastric Cancer
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- Biomarkers for Precision Treatment in Gastric Cancer
- Key elements involved in Epstein–Barr virus-associated gastric cancer and their network regulation